Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of the Effect of Local Pamidronate Application in Preventing Periprosthetic Bone Loss After Total Cemented Hip Arthroplasty

NCT00548288 is registered in ClinicalTrials.gov with General and Teaching Hospital Celje as lead sponsor.

NCT NCT00548288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of the Effect of Local Pamidronate Application in Preventing Periprosthetic Bone Loss After Total Cemented Hip Arthroplasty
Lead sponsor
General and Teaching Hospital Celje
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2007
Completion date
Not reported
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, mineral density